Li Fengda, Li Zeyi, Xu Hong, Kong Gang, Zhang Ze, Cheng Kaiyuan, Gu Longyuan, Hua Lei
Department of Neurosurgery, Changshu Hospital Affiliated to Soochow University, No.1, Shuyuan Street, Changshu, 215500, China.
Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, No. 99, Huaihai West Road, Xuzhou, 221000, China.
BMC Cancer. 2025 Jul 28;25(1):1228. doi: 10.1186/s12885-025-14454-9.
To predict the 1p/19q molecular status of Lower-grade glioma (LGG) patients nondestructively, this study developed a deep learning (DL) approach using radiomic to provide a potential decision aid for clinical determination of molecular stratification of LGG.
The study retrospectively collected images and clinical data of 218 patients diagnosed with LGG between July 2018 and July 2022, including 155 cases from The Cancer Imaging Archive (TCIA) database and 63 cases from a regional medical centre. Patients' clinical data and MRI images were collected, including contrast-enhanced T1-weighted images and T2-weighted images. After pre-processing the image data, tumour regions of interest (ROI) were segmented by two senior neurosurgeons. In this study, an Ensemble Convolutional Neural Network (ECNN) was proposed to predict the 1p/19q status. This method, consisting of Variational Autoencoder (VAE), Information Gain (IG) and Convolutional Neural Network (CNN), is compared with four machine learning algorithms (Random Forest, Decision Tree, K-Nearest Neighbour, Gaussian Neff Bayes). Fivefold cross-validation was used to evaluate and calibrate the model. Precision, recall, accuracy, F1 score and area under the curve (AUC) were calculated to assess model performance.
Our cohort comprises 118 patients diagnosed with 1p/19q codeletion and 100 patients diagnosed with 1p/19q non-codeletion. The study findings indicate that the ECNN method demonstrates excellent predictive performance on the validation dataset. Our model achieved an average precision of 0.981, average recall of 0.980, average F1-score of 0.981, and average accuracy of 0.981. The average area under the curve (AUC) for our model is 0.994, surpassing that of the other four traditional machine learning algorithms (AUC: 0.523-0.702). This suggests that the model based on the ECNN algorithm performs well in distinguishing the 1p/19q molecular status of LGG patients.
The deep learning model based on conventional MRI radiomic integrates VAE and IG methods. Compared with traditional machine learning algorithms, it shows the best performance in the prediction of 1p/19q molecular co-deletion status. It may become a potentially effective tool for non-invasively and effectively identifying molecular features of lower-grade glioma in the future, providing an important reference for clinicians to formulate individualized diagnosis and treatment plans.
为了无损预测低级别胶质瘤(LGG)患者的1p/19q分子状态,本研究开发了一种利用放射组学的深度学习(DL)方法,为LGG分子分层的临床判定提供潜在的决策辅助。
本研究回顾性收集了2018年7月至2022年7月期间诊断为LGG的218例患者的图像和临床数据,其中包括来自癌症影像存档(TCIA)数据库的155例和来自某地区医疗中心的63例。收集了患者的临床数据和MRI图像,包括对比增强T1加权图像和T2加权图像。对图像数据进行预处理后,由两名资深神经外科医生分割肿瘤感兴趣区域(ROI)。在本研究中,提出了一种集成卷积神经网络(ECNN)来预测1p/19q状态。该方法由变分自编码器(VAE)、信息增益(IG)和卷积神经网络(CNN)组成,并与四种机器学习算法(随机森林、决策树、K近邻、高斯朴素贝叶斯)进行比较。采用五折交叉验证来评估和校准模型。计算精度、召回率、准确率、F1分数和曲线下面积(AUC)以评估模型性能。
我们的队列包括118例诊断为1p/19q共缺失的患者和100例诊断为1p/19q非共缺失的患者。研究结果表明,ECNN方法在验证数据集上表现出优异的预测性能。我们的模型平均精度为0.981,平均召回率为0.980,平均F1分数为0.981,平均准确率为0.981。我们模型的平均曲线下面积(AUC)为0.994,超过了其他四种传统机器学习算法(AUC:0.523 - 0.702)。这表明基于ECNN算法的模型在区分LGG患者的1p/19q分子状态方面表现良好。
基于传统MRI放射组学的深度学习模型集成了VAE和IG方法。与传统机器学习算法相比,它在预测1p/19q分子共缺失状态方面表现出最佳性能。未来它可能成为一种潜在的有效工具,用于无创且有效地识别低级别胶质瘤的分子特征,为临床医生制定个体化诊断和治疗方案提供重要参考。